Genome-wide study of Pseudomonas aeruginosa outer membrane protein immunogenicity using self-assembling protein microarrays

Infection and Immunity

Volumn 77, Issue 11, 2009, Pages 4877-4886

  Montor, Wagner R ^a   Huang, Jin ^a   Hu, Yanhui ^a   Hainsworth, Eugenie ^a   Lynch, Susan ^b   Kronish, Jeannine Weiner ^b   Ordonez, Claudia L ^c   Logvinenko, Tanya ^d   Lory, Stephen ^a   LaBaer, Joshua ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; OUTER MEMBRANE PROTEIN; PROTEIN FLIC A; PROTEIN PA0044; PROTEIN PA0807; PROTEIN PA0973; PROTEIN PA1080; PROTEIN PA2300; PROTEIN PA3407; PROTEIN PA3841; PROTEIN PA3931; PROTEIN PA4110; PROTEIN PA4922; PROTEIN PA5369; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ADOLESCENT; ADULT; AMINO ACID COMPOSITION; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMORAL IMMUNITY; IMMUNOGENICITY; MICROARRAY ANALYSIS; NONHUMAN; OPEN READING FRAME; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MICROARRAY; PSEUDOMONAS AERUGINOSA; SCHOOL CHILD;

ADOLESCENT; ADULT; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BLOTTING, WESTERN; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MIDDLE AGED; PROTEIN ARRAY ANALYSIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 70350439128     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00698-09     Document Type: Article

References (45)

1. Anderson, K. S., N. Ramachandran, J. Wong, J. V. Raphael, E. Hainsworth, G. Demirkan, D. Cramer, D. Aronzon, F. S. Hodi, L. Harris, T. Logvinenko, and J. Labaer. 2008. Application of protein microarrays for multiplexed detection of antibodies to tumor antigens in breast cancer. J. Proteome Res. 7:1490-1499.
2. Beare, P. A., C. Chen, T. Bouman, J. Pablo, B. Unal, D. C. Cockrell, W. C. Brown, K. D. Barbian, S. F. Porcella, J. E. Samuel, P. L. Felgner, and R. A. Heinzen. 2008. Candidate antigens for Q fever serodiagnosis revealed by immunoscreening of a Coxiella burnetii protein microarray. Clin. Vaccine Immunol. 15:1771-1779.
3. Berven, F. S., K. Flikka, H. B. Jensen, and I. Eidhammer. 2004. BOMP: a program to predict integral beta-barrel outer membrane proteins encoded within genomes of Gram-negative bacteria. Nucleic Acids Res. 32:W394-W399.
4. Bigelow, H. R., D. S. Petrey, J. Liu, D. Przybylski, and B. Rost. 2004. Predicting transmembrane beta-barrels in proteomes. Nucleic Acids Res. 32:2566-2577.
5. Bragonzi, A., D. Worlitzsch, G. B. Pier, P. Timpert, M. Ulrich, M. Hentzer, J. B. Andersen, M. Givskov, M. Conese, and G. Doring. 2005. Nonmucoid Pseudomonas aeruginosa expresses alginate in the lungs of patients with cystic fibrosis and in a mouse model. J. Infect. Dis. 192:410-419.
6. Diaz, E., E. Munoz, K. Agbaht, and J. Rello. 2007. Management of ventilator- associated pneumonia caused by multiresistant bacteria. Curr. Opin. Crit. Care 13:45-50.
7. Döring, G., C. Meisner, and M. Stern. 2007. A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients. Proc. Natl. Acad. Sci. USA 104:11020-11025.
8. Döring, G., and G. B. Pier. 2008. Vaccines and immunotherapy against Pseudomonas aeruginosa. Vaccine 26:1011-1024.
9. Driscoll, J. A., S. L. Brody, and M. H. Kollef. 2007. The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs 67:351-368. (Pubitemid 46425550)
10. Elting, L. S., E. B. Rubenstein, K. V. Rolston, and G. P. Bodey. 1997. Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials. Clin. Infect. Dis. 25:247-259.
11. Gardy, J. L., M. R. Laird, F. Chen, S. Rey, C. J. Walsh, M. Ester, and F. S. Brinkman. 2005. PSORTb v. 2.0: expanded prediction of bacterial protein subcellular localization and insights gained from comparative proteome analysis. Bioinformatics 21:617-623.
12. Gartner, T., M. Baeten, S. Otieno, H. Revets, P. De Baetselier, and K. Huygen. 2007. Mucosal prime-boost vaccination for tuberculosis based on TLR triggering OprI lipoprotein from Pseudomonas aeruginosa fused to mycolyl-transferase Ag85A. Immunol. Lett. 111:26-35.
13. Gibson, R. L., J. L. Burns, and B. W. Ramsey. 2003. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am. J. Respir. Crit. Care Med. 168:918-951.
14. Grisshammer, R. 2006. Understanding recombinant expression of membrane proteins. Curr. Opin. Biotechnol. 17:337-340.
15. Hancock, R. E., E. C. Mouat, and D. P. Speert. 1984. Quantitation and identification of antibodies to outer-membrane proteins of Pseudomonas aeruginosa in sera of patients with cystic fibrosis. J. Infect. Dis. 149:220-226.
16. Holder, I. A. 2004. Pseudomonas immunotherapy: a historical overview. Vaccine 22:831-839.
17. Keasey, S. L., K. E. Schmid, M. S. Lee, J. Meegan, P. Tomas, M. Minto, A. P. Tikhonov, B. Schweitzer, and R. G. Ulrich. 2009. Extensive antibody crossreactivity among infectious gram-negative bacteria revealed by proteome microarray analysis. Mol. Cell. Proteomics 8:924-935.
18. Klinger, J. D., D. C. Straus, C. B. Hilton, and J. A. Bass. 1978. Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: demonstration by radioimmunoassay. J. Infect. Dis. 138:49-58.
19. Kolaskar, A. S., and P. C. Tongaonkar. 1990. A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett. 276: 172-174.
20. Kubesch, P., B. U. von Specht, and B. Tummler. 1988. Immune response in cystic fibrosis to outer membrane proteins of Pseudomonas aeruginosa. Zentralbl. Bakteriol. Mikrobiol. Hyg. A 269:395-410.
21. Labaer, J., Q. Qiu, A. Anumanthan, W. Mar, D. Zuo, T. V. Murthy, H. Taycher, A. Halleck, E. Hainsworth, S. Lory, and L. Brizuela. 2004. The Pseudomonas aeruginosa PA01 gene collection. Genome Res. 14:2190-2200.
22. Larsen, J. E., O. Lund, and M. Nielsen. 2006. Improved method for predicting linear B-cell epitopes. Immunome Res. 2:2.
23. Laurans, M., A. Arion, M. Fines-Guyon, A. Regeasse, J. Brouard, R. Leclercq, and J. F. Duhamel. 2006. Pseudomonas aeruginosa and cystic fibrosis: first colonization to chronic infection. Arch. Pediatr. 13(Suppl. 1): S22-S29. (In French.)
24. Leonard, A., T. Leal, and P. Lebecque. 2007. Cystic fibrosis and pseudomonas aeruginosa current and future strategies. J. Pharm. Belg. 62:25-28. (In French.)
25. Li, B., D. Zhou, Z. Wang, Z. Song, H. Wang, M. Li, X. Dong, M. Wu, Z. Guo, and R. Yang. 2008. Antibody profiling in plague patients by protein microarray. Microbes Infect. 10:45-51.
26. Lu, Z., D. Szafron, R. Greiner, P. Lu, D. S. Wishart, B. Poulin, J. Anvik, C. Macdonell, and R. Eisner. 2004. Predicting subcellular localization of proteins using machine-learned classifiers. Bioinformatics 20:547-556. (Pubitemid 38344335)
27. Lyczak, J. B., C. L. Cannon, and G. B. Pier. 2002. Lung infections associated with cystic fibrosis. Clin. Microbiol. Rev. 15:194-222.
28. Murthy, T., A. Rolfs, Y. Hu, Z. Shi, J. Raphael, D. Moreira, F. Kelley, S. McCarron, D. Jepson, E. Taycher, D. Zuo, S. E. Mohr, M. Fernandez, L. Brizuela, and J. Labaer. 2007. A full-genomic sequence-verified proteincoding gene collection for Francisella tularensis. PLoS ONE 2:e577. (Pubitemid 351260204)
29. Obritsch, M. D., D. N. Fish, R. MacLaren, and R. Jung. 2005. Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options. Pharmacotherapy 25:1353-1364. (Pubitemid 41407633)
30. Parker, J. M., D. Guo, and R. S. Hodges. 1986. New hydrophilicity scale derived from high-performance liquid chromatography peptide retention data: correlation of predicted surface residues with antigenicity and X-rayderived accessible sites. Biochemistry 25:5425-5432.
31. Peters, B., J. Sidney, P. Bourne, H. H. Bui, S. Buus, G. Doh, W. Fleri, M. Kronenberg, R. Kubo, O. Lund, D. Nemazee, J. V. Ponomarenko, M. Sathiamurthy, S. Schoenberger, S. Stewart, P. Surko, S. Way, S. Wilson, and A. Sette. 2005. The immune epitope database and analysis resource: from vision to blueprint. PLoS Biol. 3:e91.
32. Ramachandran, N., K. S. Anderson, J. Raphael, E. Hainsworth, S. Sibani, W. R. Montor, M. Pacek, J. Wong, M. Eljanne, M. G. Sanda, Y. Hu, T. Logvinenko, and J. Labaer. 2008. Tracking humoral responses using self assembling protein microarrays. Proteomics Clin. Appl. 2:1518-1527.
33. Ramachandran, N., E. Hainsworth, B. Bhullar, S. Eisenstein, B. Rosen, A. Y. Lau, J. C. Walter, and J. LaBaer. 2004. Self-assembling protein microarrays. Science 305:86-90.
34. Ramachandran, N., J. V. Raphael, E. Hainsworth, G. Demirkan, M. G. Fuentes, A. Rolfs, Y. Hu, and J. Labaer. 2008. Next-generation high-density self-assembling functional protein arrays. Nat. Methods 5:535-538. (Pubitemid 351761761)
35. Ramsey, D. M., and D. J. Wozniak. 2005. Understanding the control of Pseudomonas aeruginosa alginate synthesis and the prospects for management of chronic infections in cystic fibrosis. Mol. Microbiol. 56:309-322.
36. Ratjen, F., H. Walter, M. Haug, C. Meisner, H. Grasemann, and G. Doring. 2007. Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients. Pediatr. Pulmonol. 42:249-255.
37. Rice, P., I. Longden, and A. Bleasby. 2000. EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet. 16:276-277.
38. Saiman, L. 2004. Microbiology of early CF lung disease. Paediatr. Respir. Rev. 5(Suppl. A):S367-S369.
39. Sundaresh, S., A. Randall, B. Unal, J. M. Petersen, J. T. Belisle, M. G. Hartley, M. Duffield, R. W. Titball, D. H. Davies, P. L. Felgner, and P. Baldi. 2007. From protein microarrays to diagnostic antigen discovery: a study of the pathogen Francisella tularensis. Bioinformatics 23:i508-i518. (Pubitemid 47244438)
40. Taycher, E., A. Rolfs, Y. Hu, D. Zuo, S. E. Mohr, J. Williamson, and J. Labaer. 2007. A novel approach to sequence validating protein expression clones with automated decision making. BMC Bioinformatics 8:198. (Pubitemid 47064574)
41. Wagner, S., M. L. Bader, D. Drew, and J. W. de Gier. 2006. Rationalizing membrane protein overexpression. Trends Biotechnol. 24:364-371.
42. West, S. E., L. Zeng, B. L. Lee, M. R. Kosorok, A. Laxova, M. J. Rock, M. J. Splaingard, and P. M. Farrell. 2002. Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors. JAMA 287:2958-2967.
43. Woods, D. E., S. J. Cryz, R. L. Friedman, and B. H. Iglewski. 1982. Contribution of toxin A and elastase to virulence of Pseudomonas aeruginosa in chronic lung infections of rats. Infect. Immun. 36:1223-1228.
44. Xu, Y., J. F. Bruno, and B. J. Luft. 2008. Profiling the humoral immune response to Borrelia burgdorferi infection with protein microarrays. Microb. Pathog. 45:403-407.
45. Zhu, H., S. Hu, G. Jona, X. Zhu, N. Kreiswirth, B. M. Willey, T. Mazzulli, G. Liu, Q. Song, P. Chen, M. Cameron, A. Tyler, J. Wang, J. Wen, W. Chen, S. Compton, and M. Snyder. 2006. Severe acute respiratory syndrome diagnostics using a coronavirus protein microarray. Proc. Natl. Acad. Sci. USA 103:4011-4016.